title: Allo-HCT regimens with low toxicity needed in older patients with acute myeloid leukaemia--Authors' reply.
authors.affiliation: Hematology and BMT Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, 24127, Italy. Electronic address: arambaldi@hpg23.it.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Rambaldi
authors.affiliation: Hematology and BMT Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, 24127, Italy.
authors.forename: Arianna
authors.initials: A
authors.lastname: Masciulli
authors.affiliation: Hematology and BMT Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, 24127, Italy.
authors.forename: Cristina
authors.initials: C
authors.lastname: Boschini
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002066:Busulfan / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D060828:Induction Chemotherapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000601:surgery*; D008297:Male; D019172:Transplantation Conditioning; D014740:Vidarabine / Q000031:analogs & derivatives*
chemical_list: D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D014740:Vidarabine; D002066:Busulfan